Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released May 13, 2022, before the open
10-Q filed May 13, 2022, 43 days after period end · 0000950170-22-009812
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $0.00 | — | $6.02K | $2.50K |
| Net Income | -$4.21M | -$4.03M | -$2.38M | -$3.11M |
| EPS Diluted | -$12.96 |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$0.79 |
| -$5.58 |
| -$3.42 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
